Inducible dopaminergic glutathione depletion in an alpha-synuclein transgenic mouse model results in age-related olfactory dysfunction

Neuroscience

Volumn 172, Issue , 2011, Pages 379-386

  Kim, Y H ^a   Lussier, S ^a   Rane, A ^a   Choi, S W ^a   Andersen, J K ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Mitochondrial dysfunction; Neurodegeneration; Olfactory deficits; Oxidative stress; Parkinson's disease; Smell test

Indexed keywords

ALPHA SYNUCLEIN; DOXYCYCLINE; GLUTATHIONE;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CELL LEVEL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE OVEREXPRESSION; GRANULE CELL; MITOCHONDRIAL RESPIRATION; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OLFACTORY BULB; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DEPLETION; SMELLING; SMELLING DISORDER;

AGING; ALPHA-SYNUCLEIN; ANIMALS; DOPAMINE; FEMALE; GLUTATHIONE; MALE; MICE; MICE, TRANSGENIC; NEURODEGENERATIVE DISEASES; OLFACTION DISORDERS; OLFACTORY BULB; OXIDATIVE STRESS; PARKINSON DISEASE; UP-REGULATION;

EID: 78650723904     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.10.072     Document Type: Article

References (28)

1. Arnold S.E., Smutzer G.S., Trojanowski J.Q., Moberg P.J. Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer's disease and schizophrenia. Ann N Y Acad Sci 1998, 855:762-775.
2. Attems J., Lintner F., Jellinger K.A. Olfactory involvement in aging and Alzheimer's disease: an autopsy study. J Alzheimers Dis 2005, 7(2):149-157. discussion 173-180.
3. Beach T.G., White C.L., Hladik C.L., Sabbagh M.N., Connor D.J., Shill H.A., Sue L.I., Sasse J., Bachalakuri J., Henry-Watson J., et al. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 2009, 117(2):169-174.
4. Berendse H.W., Booij J., Francot C.M., Bergmans P.L., Hijman R., Stoof J.C., Wolters E.C. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol 2001, 50(1):34-41.
5. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24(2):197-211.
6. Cave J.W., Baker H. Dopamine systems in the forebrain. Adv Exp Med Biol 2009, 651:15-35.
7. Chinta S.J., Kumar M.J., Hsu M., Rajagopalan S., Kaur D., Rane A., Nicholls D.G., Choi J., Andersen J.K. Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration. J Neurosci 2007, 27(51):13997-14006.
8. Choi S.W., Gerencser A.A., Nicholls D. Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failure. J Neurochem 2009, 109(4):1179-1191.
9. Desplats P., Lee H.J., Bae E.J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S.J. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A 2009, 106(31):13010-13015.
10. Doty R.L. Olfaction in Parkinson's disease. Parkinsonism Relat Disord 2007, 13(Suppl 3):S225-S228.
11. Doty R.L. The olfactory system and its disorders. Semin Neurol 2009, 29(1):74-81.
12. Fleming S.M., Tetreault N.A., Mulligan C.K., Hutson C.B., Masliah E., Chesselet M.F. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci 2008, 28(2):247-256.
13. Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., Masliah E. Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 2000, 157(2):401-410.
14. Huisman E., Uylings H.B., Hoogland P.V. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients. Mov Disord 2008, 23(10):1407-1413.
15. Kovács T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res Rev 2004, 3(2):215-232.
16. Lafreniere D., Mann N. Anosmia: loss of smell in the elderly. Otolaryngol Clin North Am 2009, 42(1):123-131.
17. Lerner A., Bagic A. Olfactory pathogenesis of idiopathic Parkinson disease revisited. Mov Disord 2008, 23(8):1076-1084.
18. Liu G., Zhang C., Yin J., Li X., Cheng F., Li Y., Yang H., Uéda K., Chan P., Yu S. Alpha-synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity. Neurosci Lett 2009, 454(3):187-192.
19. Lu X.H., Fleming S.M., Meurers B., Ackerson L.C., Mortazavi F., Lo V., Hernandez D., Sulzer D., Jackson G.R., Maidment N.T., Chesselet M.F., Yang X.W. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J Neurosci 2009, 29(7):1962-1976.
20. Luzzi S., Piccirilli M., Provinciali L. Perception of emotions on happy/sad chimeric faces in Alzheimer disease: relationship with cognitive functions. Alzheimer Dis Assoc Disord 2007, 21(2):130-135.
21. Reed R.R., Bakalyar H.A., Cunningham A.M., Levy N.S. The molecular basis of signal transduction in olfactory sensory neurons. Soc Gen Physiol Ser 1992, 47:53-60.
22. Simuni T., Sethi K. Nonmotor manifestations of Parkinson's disease. Ann Neurol 2008, 64(Suppl 2):S65-S80.
23. Sobel N., Thomason M.E., Stappen I., Tanner C.M., Tetrud J.W., Bower J.M., Sullivan E.V., Gabrieli J.D. An impairment in sniffing contributes to the olfactory impairment in Parkinson's disease. Proc Natl Acad Sci U S A 2001, 98(7):4154-4159.
24. Taylor T.N., Caudle W.M., Shepherd K.R., Noorian A., Jackson C.R., Iuvone P.M., Weinshenker D., Greene J.G., Miller G.W. Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci 2009, 29(25):8103-8113.
25. Tillerson J.L., Caudle W.M., Parent J.M., Gong C., Schallert T., Miller G.W. Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behav Brain Res 2006, 172(1):97-105.
26. Ubeda-Bañon I., Saiz-Sanchez D., de la Rosa-Prieto C., Argandoña-Palacios L., Garcia-Muñozguren S., Martinez-Marcos A. Alpha-synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells. Acta Neuropathol 2010, 119(6):723-735.
27. Ward C.D., Hess W.A., Calne D.B. Olfactory impairment in Parkinson's disease. Neurology 1983, 33(7):943-946.
28. Wattendorf E., Welge-Lüssen A., Fiedler K., Bilecen D., Wolfensberger M., Fuhr P., Hummel T., Westermann B. Olfactory impairment predicts brain atrophy in Parkinson's disease. J Neurosci 2009, 29(49):15410-15413.